Show items per page
Elements: 177
Page 1 on 9
 TitleAuthors / EditorsDate
add to browser selection
Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT Masouridi Levrat, Stavroula; Olavarria, Eduardo; Iacobelli, Simona; Aljurf, Mahmoud; ... Agha, Ibrahim Yakoub 2022
add to browser selection
Invasive Mold Infections in Allogeneic Hematopoietic Cell Transplant Recipients in 2020: Have We Made Enough Progress? Roth, Romain; Masouridi Levrat, Stavroula; Chalandon, Yves; Mamez, Anne-Claire; ... Neofytos, Dionysios 2022
add to browser selection
Frequency and causes of antifungal treatment changes in allogeneic haematopoïetic cell transplant recipients with invasive mould infections Roth, Romain; Masouridi Levrat, Stavroula; Giannotti, Federica; Mamez, Anne-Claire; ... Neofytos, Dionysios 2022
add to browser selection
GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation Mlakar, Simona; Uppugunduri Satyanarayana, Chakradhara Rao; Nava, Tiago; Mlakar, Vid; ... Ansari Djaberi, Marc Georges 2022
add to browser selection
Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study Greinix, Hildegard T; Eikema, Dirk-Jan; Koster, Linda; Penack, Olaf; ... Kröger, Nicolaus 2022
add to browser selection
Risk factors for a severe form of COVID-19 after allogeneic haematopoietic stem cell transplantation: a Société Francophone de Greffe de Moelle et de Thérapie cellulaire (SFGM-TC) multicentre cohort study Xhaard, Alienor; Xhaard, Constance; D'Aveni, Maud; Salvator, Helene; ... Rubio, Marie-Therese 2021
add to browser selection
Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS Janssen, Jeroen; Löwenberg, Bob; Manz, Markus; Bargetzi, Mario; ... Ossenkoppele, Gert 2021
add to browser selection
Clinical and Pharmacological Considerations for Concomitant Administration of Posaconazole and Isavuconazole with Letermovir Terrier, Jean; Zanella, Marie-Céline; Masouridi Levrat, Stavroula; Kronig, Ilona; ... Neofytos, Dionysios 2021
add to browser selection
Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipients Kraljevic, Mateja; Khanna, Nina; Medinger, Michael; Passweg, Jakob; ... Neofytos, Dionysios 2021
add to browser selection
Predictors of breakthrough clinically significant cytomegalovirus infection during letermovir prophylaxis in high-risk hematopoietic cell transplant recipients Royston, Lena; Royston, Eva; Masouridi Levrat, Stavroula; Chalandon, Yves; ... Neofytos, Dionysios 2021
add to browser selection
Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018 Kohler, Philipp; Wolfensberger, Aline; Stampf, Susanne; Brönnimann, Andreas; ... Mueller, Nicolas J 2021
add to browser selection
Letermovir Primary Prophylaxis in High-Risk Hematopoietic Cell Transplant Recipients: A Matched Cohort Study Royston, Lena; Royston, Eva; Masouridi Levrat, Stavroula; Vernaz, Nathalie; ... Neofytos, Dionysios 2021
add to browser selection
Unmasking viral sequences by metagenomic next-generation sequencing in adult human blood samples during steroid-refractory/dependent graft-versus-host disease Zanella, Marie-Céline; Cordey, Samuel; Laubscher, Florian; Docquier, Mylene; ... Vu Cantero, Diem-Lan 2021
add to browser selection
Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial Seydoux, Claire; Medinger, Michael; Gerull, Sabine; Halter, Joerg; ... Cantoni, Nathan 2021
add to browser selection
Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantation Buhler, Stéphane; Baldomero, Helen; Ferrari-Lacraz, Sylvie; Mamez, Anne-Claire; ... Villard, Jean 2021
add to browser selection
Successful treatment of central nervous system lymphoproliferative disorder in a kidney-pancreas and stem cell transplanted patient using intrathecal rituximab Anastasiou, Maria; Mamez, Anne-Claire; Masouridi Levrat, Stavroula; Vargas Gomez, Maria Isabel; ... Chalandon, Yves 2021
add to browser selection
Use of induction therapy in pediatric heart transplant recipients in Switzerland - Analysis of the Swiss national database Schweiger, M; Erdil, T; Di Bernardo, S; Balmer, C; ... Kadner, A 2021
add to browser selection
Pre-transplant donor-specific HLA antibodies and risk for poor first-year renal transplant outcomes: results from the Swiss Transplant Cohort Study Wehmeier, Caroline; Amico, Patrizia; Sidler, Daniel; Wirthmüller, Urs; ... Schaub, Stefan 2021
add to browser selection
Improved outcome in children compared to adolescents and young adults after allogeneic hematopoietic stem cell transplant for acute myeloid leukemia: a retrospective study from the Francophone Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC) Pochon, Cécile; Detrait, Marie; Dalle, Jean-Hugues; Michel, Gérard; ... Rubio, Marie-Thérèse 2021
add to browser selection
The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graft Beauverd, Yan; Morin, Sarah; Stephan, Caroline; De Ramon Ortiz, Carmen Julia; ... Chalandon, Yves 2021
<< previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 |